NCT06919757

Brief Summary

During intrauterine life, some babies are smaller or grow less than expected. This fetal growth abnormality, called fetal growth restriction (FGR), can be diagnosed by ultrasound. Since there are currently no curative treatments for this condition, nor methods to optimize the growth of babies in the womb, the only effective strategy is intensive monitoring of fetal conditions, accompanied by early planning of delivery. The diagnosis of early FGR (i.e. diagnosed before 32 weeks of gestation) confers a greater risk of short- and long-term respiratory problems. The study aims to examine the association between parameters that can be assessed during pregnancy by ultrasound, such as the estimate of lung volumes, the thickness and contractility of the diaphragm, and cardiac kinetics, and any perinatal complications and respiratory function in the first years of life of premature infants, both with and without evidence of fetal growth pathology. Therefore, the study is divided into two phases: a prenatal and a postnatal phase. The study includes two groups of patients:

  1. 1.Study group: Fetuses and preterm infants with a prenatal history of FGR;
  2. 2.Control group: Preterm infants without a prenatal history of FGR followed during neonatal follow-up.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for all trials

Timeline
10mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Apr 2025Mar 2027

First Submitted

Initial submission to the registry

April 2, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 9, 2025

Completed
11 days until next milestone

Study Start

First participant enrolled

April 20, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

August 26, 2025

Status Verified

August 1, 2025

Enrollment Period

1.9 years

First QC Date

April 2, 2025

Last Update Submit

August 25, 2025

Conditions

Keywords

lung volume measurementspulmonary function testpreterm birthintrauterine growth retardationoxygen saturation/physiology

Outcome Measures

Primary Outcomes (3)

  • Bronchopulmonary dysplasia

    Respiratory support at 36 weeks post-menstrual age

    36 weeks post-menstrual age

  • Death

    occurrence of death during NICU admission or afterwards

    2 years of life

  • Lung function data

    Data from the Tidal breathing flow volume test and multiple breath nitrogen washout

    2 years of life

Secondary Outcomes (2)

  • Peripheral oxygen saturation/fraction on inspired oxygen ratio (SFR)

    16 weeks of life

  • Peripheral oxygen saturation/fraction on inspired oxygen ratio divided by mean airway pressure (SFR/P)

    16 weeks of life

Study Arms (2)

Infants born preterm with history of IUGR

preterm infants with history of intrauterine growth restriction

Diagnostic Test: fetal ultrasound to assess lungs, heart and diaphragm

Infants born preterm without history of IUGR

preterm infants without history of intrauterine growth restriction

Diagnostic Test: fetal ultrasound to assess lungs, heart and diaphragm

Interventions

The potential association between fetal ultrasound parameters (estimation of lung volumes, diaphragmatic thickness and contractility, cardiac thickness and kinetics), perinatal complications and respiratory function in the first years of life will be studied. Variables include: neonatal complications, non-invasive markers of respiratory status during neonatal admission (e.g. peripheral oxygen saturation/rfaction of inspired oxygen ratio among others), lung function tests in the first two years of life.

Also known as: lung function tests
Infants born preterm with history of IUGRInfants born preterm without history of IUGR

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Fetuses and Infants born before 32 weeks of gestation, with and without fetal growth restriction

You may qualify if:

  • Fetuses and Infants born before 32 weeks of gestation, with and without fetal growth restriction

You may not qualify if:

  • Lack of informed consent
  • Need for palliative care
  • Major malformations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Gemelli IRCCS

Roma, 00168, Italy

RECRUITING

Related Publications (6)

  • Nobile S, Marchionni P, Carnielli VP. Neonatal outcome of small for gestational age preterm infants. Eur J Pediatr. 2017 Aug;176(8):1083-1088. doi: 10.1007/s00431-017-2957-1. Epub 2017 Jun 28.

    PMID: 28660312BACKGROUND
  • Jensen EA, Foglia EE, Dysart KC, Simmons RA, Aghai ZH, Cook A, Greenspan JS, DeMauro SB. Adverse effects of small for gestational age differ by gestational week among very preterm infants. Arch Dis Child Fetal Neonatal Ed. 2019 Mar;104(2):F192-F198. doi: 10.1136/archdischild-2017-314171. Epub 2018 May 5.

    PMID: 29730594BACKGROUND
  • D'Agostin M, Di Sipio Morgia C, Vento G, Nobile S. Long-term implications of fetal growth restriction. World J Clin Cases. 2023 May 6;11(13):2855-2863. doi: 10.12998/wjcc.v11.i13.2855.

    PMID: 37215406BACKGROUND
  • Arigliani M, Stocco C, Valentini E, De Pieri C, Castriotta L, Ferrari ME, Canciani C, Driul L, Orsaria M, Cattarossi L, Cogo P. Lung function between 8 and 15 years of age in very preterm infants with fetal growth restriction. Pediatr Res. 2021 Sep;90(3):657-663. doi: 10.1038/s41390-020-01299-0. Epub 2021 Jan 19.

    PMID: 33469172BACKGROUND
  • Nobile S, Marchionni P, Gidiucci C, Correani A, Palazzi ML, Spagnoli C, Rondina C; Marche Neonatal Network; Carnielli VP. Oxygen saturation/FIO2 ratio at 36 weeks' PMA in 1005 preterm infants: Effect of gestational age and early respiratory disease patterns. Pediatr Pulmonol. 2019 May;54(5):637-643. doi: 10.1002/ppul.24265. Epub 2019 Jan 27.

    PMID: 30688034BACKGROUND
  • Salem Y, Willers CC, Amylidi-Mohr S, Kentgens AC, Stranzinger E, Latzin P, Raio L, Yammine S. Low Birth Weight and Impaired Later Lung Function: Results from a Monochorionic Twin Study. Ann Am Thorac Soc. 2022 Nov;19(11):1856-1864. doi: 10.1513/AnnalsATS.202112-1349OC.

    PMID: 35580242BACKGROUND

MeSH Terms

Conditions

Fetal Growth RetardationPremature Birth

Interventions

Respiratory Function Tests

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGrowth DisordersPathologic ProcessesPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor Complications

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Stefano Nobile, MD, PhD, MSc

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stefano Nobile, MD, PhD, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2025

First Posted

April 9, 2025

Study Start

April 20, 2025

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

August 26, 2025

Record last verified: 2025-08

Locations